Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
CGTX
#3321
Cognition Therapeutics, Inc. Common Stock
1.0
9
-5.22%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-5.22%
Variazione Mensile
-18.66%
Variazione di 6 mesi
-58.87%
Variazione Annuale
+142.22%
Chiusura Precedente
1.1
5
Open
1.0
9
Bid
Ask
Low
1.0
9
High
1.0
9
Volume
16
Mercati
Mercato Azionario Statunitense
Salute
CGTX
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
22.58 M
29.26 M
39 M
61.97 M
—
Valuation ratios
Enterprise value
87.98 M
18.43 M
45.74 M
18.45 M
119.97 M
Price to earnings ratio
-2.02
-2.25
-2.26
-0.82
-4.89
Price to sales ratio
24.56
1 730.8
2 157.65
-142.89
—
Price to cash flow ratio
9.04
2.61
3.64
0.98
4.62
Price to book ratio
0.64
1.2
2.38
1.49
3.1
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
-0.2
-0.42
-0.73
-1.12
-1.08
Return on equity %
-0.23
-0.53
-1.05
-1.81
-2.2
Return on invested capital %
-7 279.36
-4 738.31
-4 705.93
-7 741.22
—
Gross margin %
100
100
100
100
—
Operating margin %
-2 140.57
-155.54 K
-187.87 K
27.67 K
—
EBITDA margin %
—
—
—
—
—
Net margin %
-876.95
-76.42 K
-95.51 K
17.42 K
—
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
7.5
6.11
3.37
2.65
12.73
Inventory turnover
—
—
—
—
—
Asset turnover
0.02
0
0
-0.01
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.7
-0.78
-0.53
-0.72
-0.54
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
10.54
1.76
1
0.63
1.65
Net current asset value per share
11.36
2.02
1.14
0.74
2.06
Tangible book value per share
9.88
1.7
0.82
0.47
1.32
Working capital per share
9.85
1.69
0.8
0.46
1.3
Book value per share
9.88
1.7
0.82
0.47
1.32
Notizie
Cognition Therapeutics incontra la FDA per farmaco contro la demenza a corpi di Lewy
Cognition Therapeutics holds FDA meeting on Lewy bodies dementia drug
Il farmaco DLB di Cognition mostra risultati positivi in trial di fase 2
Cognition’s DLB drug shows positive results in phase 2 trial
Cognition Therapeutics completa l’arruolamento nel programma di accesso esteso
Cognition Therapeutics completes enrollment in expanded access program
Cognition Therapeutics delinea i piani di Fase 3 per farmaco contro l’Alzheimer
Cognition Therapeutics outlines Phase 3 plans for Alzheimer’s drug
Cognition Therapeutics: A High-Stakes Bet On A Single Drug - Why I Hold (NASDAQ:CGTX)
Cognition Therapeutics completa l’arruolamento nella sperimentazione di farmaco per l’Alzheimer
Cognition Therapeutics completes enrollment in Alzheimer’s drug trial
Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year?